Previous 10 | Next 10 |
Listen on the go! A daily podcast of Wall Street Breakfast's Alpha Talks will be available this morning on Seeking Alpha, iTunes, Stitcher and Spotify. Stocks faded late to finish mostly flat on Friday, as investors awaited final election vote tallies in four key states, and stimulus negotiat...
Equillium (EQ) announces preliminary results from a Phase 1b open-label dose-escalation study, EQUATE, evaluating lead candidate itolizumab for the treatment of acute graft-versus-host disease (aGVHD) in a first-line setting, a Fast Track- and Orphan Drug-tagged indication in the U.S.The over...
100% overall response rate in dose cohort 3 and 80% overall response rate across all cohorts to date Complete response observed in seven of eight responding patients EQUATE P hase 1b toplin...
Studies further validate ongoing clinical development of itolizumab for the treatment of systemic lupus erythematosus and lupus nephritis LA JOLLA, Calif., Nov. 04, 2020 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: ...
Protagonist Therapeutics to develop oral IL-23 receptor antagonists with Janssen. Aligos Therapeutics initiates ALG-000184 proof-of-concept study. Equillium goes ahead with Phase 3 trial for COVID-19 vaccine. For further details see: Protagonist Janssen Collaboration, An...
Gainers: Endurance International (EIGI) +61%.Superior Industries International (SUP) +35%.DBV Technologies (DBVT) +32%.Renren (RENN) +22%.Digital Ally (DGLY) +21%.Dunxin Financial (DXF) +19%.Par Pacific Holdings (PARR) +18%.Tricida (TCDA) +18%.Lumber Liquidators (LL) +17%.Vislink Technol...
Liquidia Technologies(LQDA) -37% on rescheduling special meeting of stockholders and reaffirms recommendation to approve proposed acquisition of RareGen.Air Industries (AIRI) -11%.Orchard Therapeutics (ORTX) -8% to host Virtual R&D Investor Event on Friday, November 13.Mira...
Air Industries Group (AIRI) +53% on Q3 results.Equillium (EQ) +24% after FDA gives green signal to it's late-stage COVID-19 trial.BioLineRx (BLRX) +24% on positive late-stage data on lead candidate.Trevena (TRVN) +20%.Miragen Therapeutics (MGEN) +12%.Aldeyra Ther...
Equillium (EQ) jumps 18% after-hours after receiving a Study May Proceed letter from the FDA to begin a Phase 3 clinical trial, named EQUINOX, evaluating itolizumab in hospitalized COVID-19 patients suffering from acute respiratory distress syndrome ((ARDS)).The company plans to sta...
Gainers: [[TRUP]] +16%. [[EQ]] +15.8%. [[PLT]] +14.8%. [[MHK]] +12.3%. [[SBBP]] +10%.Losers: [[AXGT]] -41%. [[COLM]] -16.4%. [[TWTR]] -15.8%. [[UUU]] -12.5%. [[OPK]] -8.3%. For further details see: TWTR, OPK, MHK and TRUP among after-hours movers
News, Short Squeeze, Breakout and More Instantly...
Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company focused on developing novel therapeutics to treat severe autoimmune and inflammatory disorders, today announced that it will be participating in the Leerink Partners Therapeutic Forum: I&I and Metabolism, as well as the Jone...
Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company focused on developing novel therapeutics to treat severe autoimmune and inflammatory disorders, today announced that it expects to join the Russell Microcap Index at the conclusion of the 2024 Russell annual reconstitution, effe...
A look at the top 10 most actives in the United States SOBR Safe Inc. (SOBR) rose 74.6% to $0.46 on volume of 265,324,361 shares MicroAlgo Inc. (MLGO) rose 669.9% to $12.01 on volume of 183,977,846 shares PROSHARES TRUST (SQQQ) fell 0.7% to $9.86 on volume of 124,114,596 shares Faraday ...